More news – Page 4
-
NewsNovartis to site seventh new facility in North Carolina
New active pharmaceutical ingredient (API) facility in Morrisville to enable end‑to‑end manufacturing in the US.
-
NewsFDA marks progress in implementing real-time clinical trials
Advances agency’s goal in facilitating continuous trials, aimed at accelerating promising therapies.
-
NewsBioplastic produced from hemp waste potential eco-alternative for packaging films
Plant-based biocomposites improved resource efficiency and added value from biomass waste, study shows.
-
NewsCPHI Americas 2026 returns to Philadelphia with AI, regulatory focus
The annual conference for contract pharmaceutical manufacturing partners returns to Pennsylvania, centering on regulatory shifts, AI and biotech innovation.
-
NewsBoehringer’s GLP-1 dual agonist survodutide shines in phase III trial
Survodutide could become first global glucagon/GLP-1 dual agonist, new phase III findings suggest.
-
NewsFDA approves Breztri as first triple-therapy inhaler for asthma
AstraZeneca’s Breztri Aerosphere has become the first fixed-dose triple-combination inhaler approved by the FDA for asthma maintenance treatment in adults and adolescents aged 12 and older, addressing unmet needs for approximately 13.5 million US patients uncontrolled on dual therapies.
-
NewsLilly adds potential first-in-class Type II JAK2 inhibitor to haematology portfolio
The pharmaceutical company’s $2.3 billion acquisition of Ajax Therapeutics set to advance outcomes for myeloproliferative neoplasms.
-
NewsOtarmeni Regeneron’s first genetic medicine to gain approval
Authorisation of the AAV gene therapy in the US marks a milestone for treating genetic hearing loss.
-
NewsNovel NMR-based method could facilitate safer API manufacturing
The innovative approach for detecting nitrosamine impurities in APIs addresses limitations of traditional mass-based techniques, research says.
-
NewsAmgen’s Chief Technology Officer Dr David Reese to retire
His two-decade tenure at the biopharmaceutical company has strengthened its aim for “convergent innovation” in medicine development.
-
NewsAbbVie expands US footprint with new $1.4 billion manufacturing campus
Small volume parenteral (SVP) manufacturing investment represents company’s largest capital investment to date.
-
NewsManufacturing data innovation set to accelerate medicine development
CMAC’s milestone aids the pharmaceutical industry’s transition from manual and siloed data operations to connected, intelligent manufacturing systems.
-
NewsDigital framework could optimise pharmaceutical wastewater treatment design
Combining machine learning and modelling has shown promise for supporting efficient tetracycline degradation and minimising electrical energy consumption in wastewater treatment.
-
NewsUCB expands into regenerative cell therapy through $1.15bn Neurona acquisition
Epilepsy-focused acquisition accelerates UCB’s entry into developing next generation disease-modifying therapies.
-
NewsFUJIFILM Biotechnologies opens new QC lab in Denmark
New facility expands CDMO’s quality control footprint and biomanufacturing operations.
-
NewsFood-grade materials potential alternative for one-dose pharmaceutical packaging
Food packaging films could enhance stability of hygroscopic medications, supporting improved therapeutic outcomes, study finds.
-
NewsNew FDA draft guidance to enhance safety of genome editing therapies
Recommendations support next-generation sequencing-based safety evaluation of off-target editing for personalised gene therapies.
-
NewsRegeneron and Telix collaborate to advance biologics-based radiopharmaceuticals
Potential $4.3 billion partnership deal to develop next-generation radiopharmaceutical therapies for hard-to-treat cancers.
-
NewsEuropean Commission expands Dupixent approval in chronic spontaneous urticaria
New EU authorisation gives monoclonal antibody potential as new standard of care for the chronic skin condition.
-
NewsAnalytical framework demonstrates potential in single-use chromatographic purification
Digitally-driven technique supports development of autonomous, continuous biomanufacturing technologies.